725 Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)

Morgan Michalet; Philippe Ronchin; Thomas Reynaud; Nicolas Demogeot; Simon Thézenas; Jean-Michel Hannoun-Lévi; Naji Salem; Magali Quivrin; Catherine Durdux; Nazim Khalladi; David Azria

doi:10.1016/S0167-8140(25)04311-7

Retour

725 Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)

Article de revue

Avec comité de lecture

725 Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)

Morgan Michalet, Philippe Ronchin, Thomas Reynaud, Nicolas Demogeot, Simon Thézenas, Jean-Michel Hannoun-Lévi, Naji Salem, Magali Quivrin, Catherine Durdux, Nazim Khalladi, …

Radiotherapy and oncology, Vol.206, pp.S1893-S1895

05/2025

DOI: https://doi.org/10.1016/S0167-8140(25)04311-7

Indicateurs

1 Consultations de la notice

Détails

Titre: 725 Concurrent chemoradiotherapy with Cisplatin and Gemcitabine in muscle-invasive bladder cancer: results of a prospective phase II trial (NCT01495676)
Créateurs - sans rôle: Morgan Michalet
Philippe Ronchin
Thomas Reynaud
Nicolas Demogeot
Simon Thézenas
Jean-Michel Hannoun-Lévi
Naji Salem
Magali Quivrin
Catherine Durdux
Nazim Khalladi
David Azria
Détails de publication: Radiotherapy and oncology, Vol.206, pp.S1893-S1895
Identifiants: 99141153809311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article